Sandra Levy
ARTICLES BY THIS AUTHOR
- 12/27/2022
ANI intros generic Carnitor
Generic Carnitor is used for the treatment of primary systemic carnitine deficiency. - 12/26/2022
Yaral Pharma launches in the U.S.
Yaral Pharma will begin commercializing the first product from IBSA’s corporate pipeline of authorized generics in January 2023. - 12/26/2022
CSL Behring obtains FDA OK for Hemgenix
Hemgenix is the first gene therapy to treat adults with Hemophilia B. - 12/26/2022
Mars acquires Trü Frü
Trü Frü, a whole-fruit snacking brand, will operate as business unit within Mars. - 12/21/2022
What causes employees to quit and how can it be prevented?
Employee well-being experts Loopin has highlighted six of the major factors in the workplace that could lead to a high staff turnover. - 12/21/2022
Sun Pharma gains FDA OK for Sezaby
Sezaby is the first and only product approved for treating seizures in neonatal patients. - 12/21/2022
Eagle receives FDA nod for new indication for Pemfexy
The additional indication is for the initial treatment of patients with metastatic, non-squamous, non-small cell lung cancer with no EGFR or ALK genomic tumor aberrations. - 12/21/2022
Giant Food pharmacies offering flu, strep throat testing
Flu and strep testing are administered by Giant Food's certified in-store pharmacists or certified technicians, with results received within 10 minutes. - 12/21/2022
Retailers limiting children’s OTC pain relief products
As cases of COVID-19, flu and RSV tick up, amid a scarcity of OTC children’s pain relief products at certain locations, retailers have begun to institute product limits. - 12/20/2022
Provention Bio receives FDA nod for Tzield
Tzield is the first and only treatment indicated to delay the onset of stage 3 type 1 diabetes in adult and pediatric patients aged 8 years old and older with stage 2 type 1 diabetes.
